NCT07156071

Brief Summary

This study aims to evaluate the anti-aging and skin tone improvement effects of two facial serums over a 12-week period. It was conducted at a single research center with a 2-week washout period followed by full-face application of the test products for 12 weeks. A total of at least 120 healthy Chinese female participants aged 18 to 45 were enrolled and divided into two treatment groups:Each group included both early aging (18-29 years) and mature aging (30-45 years) subgroups, with at least 30 participants in each subgroup.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 18, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 22, 2024

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

August 20, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 4, 2025

Completed
Last Updated

September 8, 2025

Status Verified

September 1, 2025

Enrollment Period

3 months

First QC Date

August 20, 2025

Last Update Submit

September 4, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in Dermatologist-Assessed Wrinkle Attributes

    Crow's feet wrinkles, forehead wrinkles, global wrinkles, small folds on nasolabial zone and global fine lines will be evaluated by dermatologist.

    from Baseline to Week 12

  • Self-assessment Questionnaire

    Participants will complete a 5-point self-assessment questionnaire at Timm, T4w, T8w, and T12w, evaluating their perception of skin softness, smoothness, plumpness, elasticity, hydration, oil control, and visible aging signs. Ratings from 4 to 5 will be used to calculate "Top 2 box" percentage.

    12 weeks

  • Change in Dermatologist-Assessed Skin Texture and Quality Attributes

    Skin smoothness (visual), skin elasticity, skin softness, skin firmness, skin plumpness, cheek pores will be evaluated by dermatologist.

    from Baseline to Week 12

  • Change in Dermatologist-Assessed Skin Tone Attributes

    Skin radiance, skin translucency, skin pigmentation, skin fairness, skin tone evenness and skin dullness will be evaluated by dermatologist.

    from Baseline to Week 12

Secondary Outcomes (5)

  • Change in Skin Hydration Measured by Corneometer

    12 weeks

  • Change in Skin Elasticity Measured by Cutometer

    12 weeks

  • Change in Transepidermal Water Loss (TEWL) Measured by Vapometer

    12 weeks

  • Change in Facial Image-Based Skin Parameters Using VISIA-CR

    12 weeks

  • Change in Cheek Skin Surface Condition Using VisioScan VC20

    12 weeks

Study Arms (2)

Serum 1 Group

EXPERIMENTAL

Participants in this arm applied Serum 1 (Fla#897183 329) to the full face twice daily for 12 weeks. The group included both early aging (18-29 years) and mature aging (30-45 years) subgroups.

Other: Serum 1

Serum 2 Group

EXPERIMENTAL

Participants in this arm applied Serum 2 (Fla#b50198) to the full face twice daily for 12 weeks. The group included both early aging (18-29 years) and mature aging (30-45 years) subgroups.

Other: Serum 2

Interventions

Serum 1OTHER

Applied topically on the full face in the morning and evening for 12 weeks during the treatment period. Used by participants in the Serum 1 group.

Serum 1 Group
Serum 2OTHER

Applied topically on the full face in the morning and evening for 12 weeks during the treatment period. Used by participants in the Serum 2 group.

Serum 2 Group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Chinese female aged 18-45 years (evenly split among Early aging \[18-29 years\] and Mature aging \[30-45 years\]).
  • All skin types (dry, normal, oily, or mixed).
  • Currently experiencing lack of radiance, roughness, dullness, and fine lines or wrinkles on facial skin as self-claimed.
  • Early aging group (18-29 years): Must present with corresponding severity for the attributes evaluated by Dermatologist, including:
  • Skin smoothness, radiance, dullness: grade between 2 and 6 (scale 0-9);
  • Size of acne marks (PIH): size ≥ 2;
  • Small folds on nasolabial zone: grade between 1 and 3 (Skin Aging Atlas, 0-6 scale, Page 56-57).
  • Mature aging group (30-45 years): Must present with corresponding severity for the attributes evaluated by Dermatologist, including:
  • Skin smoothness, radiance, dullness: grade between 4 and 6 (scale 0-9);
  • Small folds on nasolabial zone: grade between 1 and 4 (Skin Aging Atlas, 0-6 scale, Page 56-57);
  • Forehead wrinkles: grade ≥ 2 (Skin Aging Atlas, 0-8 scale, Page 32-33);
  • Crow's feet wrinkles: grade ≥ 2 (Skin Aging Atlas, 0-6 scale, Page 40-41).
  • Regular user of serum and sunscreen products.
  • Did not participate in any clinical test or cosmetic product test on skin within the last 3 months.
  • In general good health at the time of the study.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai China-norm Quality Technical Service Co., Ltd., Shanghai, Shanghai 200072

Shanghai, China

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were assigned in parallel to one of two serum groups (Serum 1 or Serum 2), based on stratification by aging type (early aging or mature aging). The products were applied twice daily over 12 weeks.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2025

First Posted

September 4, 2025

Study Start

November 18, 2023

Primary Completion

March 1, 2024

Study Completion

March 22, 2024

Last Updated

September 8, 2025

Record last verified: 2025-09

Locations